| 000 | 01308 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250515233101.0 | ||
| 264 | 0 | _c20110203 | |
| 008 | 201102s 0 0 eng d | ||
| 022 | _a1873-4111 | ||
| 024 | 7 |
_a10.1016/j.maturitas.2010.06.018 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBarber, Thomas M | |
| 245 | 0 | 0 |
_aThe incretin pathway as a new therapeutic target for obesity. _h[electronic resource] |
| 260 |
_bMaturitas _cNov 2010 |
||
| 300 |
_a197-202 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAdipose Tissue _xmetabolism |
| 650 | 0 | 4 |
_aAnti-Obesity Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAppetite Depressants _xtherapeutic use |
| 650 | 0 | 4 | _aBody Mass Index |
| 650 | 0 | 4 | _aControlled Clinical Trials as Topic |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIncretins _xmetabolism |
| 650 | 0 | 4 |
_aInsulin _xmetabolism |
| 650 | 0 | 4 |
_aObesity _xdrug therapy |
| 650 | 0 | 4 | _aPractice Guidelines as Topic |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 |
_aWeight Loss _xdrug effects |
| 700 | 1 | _aBegbie, Helen | |
| 700 | 1 | _aLevy, Jonathan | |
| 773 | 0 |
_tMaturitas _gvol. 67 _gno. 3 _gp. 197-202 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.maturitas.2010.06.018 _zAvailable from publisher's website |
| 999 |
_c19996057 _d19996057 |
||